Latest News about ABBV
Recent news which mentions ABBV
AbbVie's Major Depressive Disorder Candidate Shows Mixed Result In Late-Stage Trials
October 29, 2021
Tickers
ABBV
From Benzinga
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
October 29, 2021
From Benzinga
Earnings Scheduled For October 29, 2021
October 29, 2021
From Benzinga
FDA Restricts Sale, Approves New Labeling Of Breast Implants
October 28, 2021
From Benzinga
Tickers
ABBV
From Motley Fool
AbbVie Takes Another Step Toward Its Post-Humira Future
October 27, 2021
From Motley Fool
From Motley Fool
7 High-Yield Stock Gems for Income-Obsessed Investors
October 26, 2021
From InvestorPlace
The 7 Best Stocks to Buy to Profit From the Rich
October 26, 2021
From InvestorPlace
Was Atea Pharmaceutical's Flop Predictable?
October 26, 2021
From Motley Fool
What Could These Clinical Results Mean for AbbVie's Shareholders?
October 25, 2021
From Motley Fool
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
A-List Executive Team, Big-Name Backers Fail to Lift Abbisko IPO
October 22, 2021
From Benzinga
Progenity Has Seven Quarters Left to Reverse Its Burn Rate
October 21, 2021
From InvestorPlace
Could This Be the Next Blockbuster Indication for Eli Lilly?
October 21, 2021
From Motley Fool
AstraZeneca Pulls Plug On MCL-1 Cancer Drug Trial
October 20, 2021
From Benzinga
7 A-Rated Dividend Stocks to Buy for Q4
October 20, 2021
From InvestorPlace
Could This Beaten-Down Biotech Stock Be the Next Buyout Target?
October 20, 2021
From Motley Fool
7 Dividend Stocks To Buy for 2022 and Hold Forever
October 20, 2021
From InvestorPlace
From Benzinga
3 Leading Healthcare Stocks to Buy in 2021 and Beyond
October 19, 2021
From Motley Fool
Why Revance Therapeutics Stock Is Getting Crushed Today
October 18, 2021
From Motley Fool
2 Best Biotech Stocks to Buy Right Now
October 18, 2021
From Motley Fool
7 Blue Chips to Shield Your Portfolio From Market Downturn
October 18, 2021
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.